Clinical Trial

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study proposes to compare a low-dose versus a high-dose buprenorphine induction scheme in 40 fentanyl using people with Opioid Use Disorder (OUD). Study participants will be randomized to either the low-dose (n=20) or high dose (n=20) group and dispensed medication daily for one week.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-07-10; most recent amendment 2025-08-06.
Status change: Recruiting → Active, Not Recruiting 2025-03-13
Status change: Not Yet Recruiting → Recruiting 2024-02-21
Trial Details
NCT Number NCT05944952
Lead Sponsor Friends Research Institute, Inc.
Collaborators: MATClinics
Conditions Opioid Use Disorder
Enrollment 40 participants
Start Date 2024-06-20
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-12